In tumors, a dual role of RANTES has been reported [8] since it may promote tumor progression, as in melanomas [9], or the spreading of tumor cells throughout the body, as in breast cancer [10]; but RANTES may also enhance immune response against tumors and associate to improved prognosis as in the case of lung cancer [11]. This evidence concerns the gene CCL5 and breast cancer.